DE60215461D1 - Serpin von bifidobakterien - Google Patents
Serpin von bifidobakterienInfo
- Publication number
- DE60215461D1 DE60215461D1 DE60215461T DE60215461T DE60215461D1 DE 60215461 D1 DE60215461 D1 DE 60215461D1 DE 60215461 T DE60215461 T DE 60215461T DE 60215461 T DE60215461 T DE 60215461T DE 60215461 D1 DE60215461 D1 DE 60215461D1
- Authority
- DE
- Germany
- Prior art keywords
- sequences
- polypeptides
- ncc2705
- pertains
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229920001184 polypeptide Polymers 0.000 abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 4
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 244000005700 microbiome Species 0.000 abstract 2
- 239000013598 vector Substances 0.000 abstract 2
- 241000186000 Bifidobacterium Species 0.000 abstract 1
- 241001608472 Bifidobacterium longum Species 0.000 abstract 1
- 206010012735 Diarrhoea Diseases 0.000 abstract 1
- 241000702670 Rotavirus Species 0.000 abstract 1
- 244000052616 bacterial pathogen Species 0.000 abstract 1
- 229940009291 bifidobacterium longum Drugs 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- LWGJTAZLEJHCPA-UHFFFAOYSA-N n-(2-chloroethyl)-n-nitrosomorpholine-4-carboxamide Chemical compound ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
- 230000002103 transcriptional effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C2220/00—Biochemical treatment
- A23C2220/20—Treatment with microorganisms
- A23C2220/202—Genetic engineering of microorganisms used in dairy technology
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
- G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
- G01N2333/8121—Serpins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Polymers & Plastics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01102050 | 2001-01-30 | ||
EP01102050A EP1227152A1 (de) | 2001-01-30 | 2001-01-30 | Bakterienstamm und Genom des Bifidobacteriums |
PCT/EP2002/000956 WO2002060932A2 (en) | 2001-01-30 | 2002-01-30 | A serpin in bifidobacteria |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60215461D1 true DE60215461D1 (de) | 2006-11-30 |
DE60215461T2 DE60215461T2 (de) | 2007-05-03 |
Family
ID=8176339
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60215461T Expired - Lifetime DE60215461T2 (de) | 2001-01-30 | 2002-01-30 | Serpin von bifidobakterien |
Country Status (12)
Country | Link |
---|---|
US (2) | US7183101B2 (de) |
EP (3) | EP1227152A1 (de) |
JP (2) | JP4570329B2 (de) |
CN (3) | CN100558896C (de) |
AT (1) | ATE342986T1 (de) |
AU (3) | AU2002302360A1 (de) |
CA (2) | CA2435664C (de) |
DE (1) | DE60215461T2 (de) |
DK (1) | DK1358332T3 (de) |
ES (2) | ES2274019T3 (de) |
PT (2) | PT1360299E (de) |
WO (3) | WO2002074798A2 (de) |
Families Citing this family (116)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001241934A1 (en) | 2000-03-03 | 2001-09-17 | Beckman Coulter Inc. | Multiplex hybridization system for identification of pathogenic mycobacterium and method of use |
EP1227152A1 (de) * | 2001-01-30 | 2002-07-31 | Société des Produits Nestlé S.A. | Bakterienstamm und Genom des Bifidobacteriums |
EP1264893A1 (de) * | 2001-06-08 | 2002-12-11 | Teagasc Dairy Products Research Centre | Biosynthese von CLA durch Bifidobakterien |
EP1462516B2 (de) * | 2001-12-03 | 2013-04-17 | Kyowa Hakko Bio Co., Ltd. | Mutierte 6-phosphogluconat-dehydrogenase |
US7268221B2 (en) | 2002-08-23 | 2007-09-11 | E.I. Du Pont De Nemours And Company | Alpha(1,6)-linked glucose oligosaccharide hydrolyzing enzyme polynucleotides and polypeptides and methods of use thereof |
EP2228379A1 (de) | 2003-04-25 | 2010-09-15 | North Carolina State University | Für Zelloberflächenproteinhomologe codierende Nukleinsäuresequenzen aus Lactobacillus acidophilus |
JP4866725B2 (ja) | 2003-06-23 | 2012-02-01 | ノース キャロライナ ステイト ユニヴァーシティー | フラクトオリゴ糖利用化合物をコードするアシドフィルス菌核酸及びその使用 |
WO2005000882A2 (en) * | 2003-06-27 | 2005-01-06 | University College Cork - National University Of Ireland, Cork | Dna fragments and proteins encoded by said dna isolated from bifidobacteria |
JP4384656B2 (ja) | 2003-06-30 | 2009-12-16 | クラサド インコーポレイテッド | 新規のガラクトシダーゼ酵素活性を生じさせるビフィドバクテリウムビフィダムの新規株 |
KR100492455B1 (ko) * | 2003-09-26 | 2005-05-30 | 주식회사 비피도 | 로바타바이러스 억제활성을 갖는 신균주 비피도 박테리움 롱검 에이알81 및 이로부터 분리된 활성단백질 |
WO2005034971A2 (en) * | 2003-10-08 | 2005-04-21 | Masami Moriyama | Antiviral agent |
US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
US7455992B2 (en) | 2004-02-23 | 2008-11-25 | North Carolina State University | Lactobacillus acidophilus nucleic acid sequences encoding protease homologues and uses therefore |
WO2005085478A2 (en) * | 2004-02-27 | 2005-09-15 | The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Detection and identification of mycobacterium and nocardia using primers and probes directed to the seca1 gene |
US7608700B2 (en) | 2004-03-08 | 2009-10-27 | North Carolina State University | Lactobacillus acidophilus nucleic acid sequences encoding stress-related proteins and uses therefor |
US7459289B2 (en) | 2004-03-08 | 2008-12-02 | North Carolina State University | Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor |
US7550576B2 (en) | 2004-08-09 | 2009-06-23 | North Carolina State University | Nucleic acid sequences encoding two-component sensing and regulatory proteins, antimicrobial proteins and uses therefor |
JP4784224B2 (ja) * | 2004-09-24 | 2011-10-05 | 味の素株式会社 | 糖鎖転移方法および糖鎖転移酵素 |
EP1814995A2 (de) | 2004-10-27 | 2007-08-08 | North Carolina State University | Nukleinsäuren aus lactobacillus acidophilus und deren verwendung |
US7495092B2 (en) | 2005-01-14 | 2009-02-24 | North Carolina State University | Compositions comprising promoter sequences and methods of use |
DK1856148T3 (da) | 2005-03-07 | 2013-05-21 | Barbara Kofler | Neuropeptider |
ES2325887T3 (es) * | 2005-05-16 | 2009-09-23 | Universite De Liege | Especie bifidobacteriana probiotica. |
AR052472A1 (es) | 2005-05-31 | 2007-03-21 | Iams Company | Lactobacilos probioticos para felinos |
EP1885383B1 (de) | 2005-05-31 | 2016-09-21 | IAMS Europe B.V. | Katzen probiotisches bifidobacterium |
GB0525857D0 (en) * | 2005-12-20 | 2006-02-01 | Product and process | |
GB0601901D0 (en) | 2006-01-31 | 2006-03-08 | Product and Process | |
GB0606112D0 (en) | 2006-03-28 | 2006-05-03 | Product and process | |
CN100389125C (zh) * | 2006-05-30 | 2008-05-21 | 中国科学院昆明动物研究所 | 无指盘臭蛙丙精肽、基因和变异体 |
WO2008093303A2 (en) | 2007-02-01 | 2008-08-07 | The Iams Company | Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts |
CN101273738B (zh) * | 2007-03-28 | 2011-06-01 | 哈尔滨正方科技有限公司 | 在常温下保持高活菌数的调配型酸性乳饮料的制备方法 |
EP2522358B1 (de) * | 2007-06-27 | 2016-11-09 | Laboratorios Ordesa, S.l. | Peptide gegen Infektionen mit Rotaviren |
EP2053122A1 (de) * | 2007-10-23 | 2009-04-29 | Nestec S.A. | Stresstolerante Bifidobakterien |
US9730968B2 (en) | 2008-04-17 | 2017-08-15 | Anaeropharma Science, Inc. | Therapeutic agent for ischemic diseases |
CN101570755B (zh) * | 2008-04-29 | 2011-09-28 | 中国农业科学院植物保护研究所 | 一种细菌源蛋白酶抑制剂新基因及其表达与应用 |
US9771199B2 (en) * | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
US9232813B2 (en) * | 2008-07-07 | 2016-01-12 | The Iams Company | Probiotic supplement, process for making, and packaging |
MX349705B (es) | 2008-11-11 | 2017-08-09 | Alimentary Health Ltd | Bifidobacterium longum. |
PT2429539T (pt) * | 2009-05-11 | 2017-01-12 | Nestec Sa | Lactobacilos johnsonii la1 ncc533 não replicativo (cncm i-1225) e distúrbios imunitários |
BRPI0925002A2 (pt) | 2009-05-27 | 2016-06-21 | Clasado Inc | uso de uma composição para a prevenção de diarréia |
EP2270134A1 (de) * | 2009-07-03 | 2011-01-05 | Nestec S.A. | Gegen oxidativen Stress resistente Bifido-Bakterien |
US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
EP2467032B1 (de) * | 2009-08-18 | 2018-02-21 | Nestec S.A. | Ernährungszusammensetzung mit bifidobacterium longum-ketten zur reduktion von lebensmittelallergiesymptomen, insbesondere bei kleinkindern und kindern |
JPWO2011027875A1 (ja) * | 2009-09-03 | 2013-02-04 | 独立行政法人理化学研究所 | 腸管バリア機能改善剤 |
EP2823822B1 (de) * | 2009-11-11 | 2016-10-12 | Alimentary Health Limited | Bifidobakteriumstamm |
AU2011206532B8 (en) | 2010-01-14 | 2015-08-06 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Recombinant probiotic bacteria for the prevention and treatment of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) |
JP5836129B2 (ja) | 2010-01-29 | 2015-12-24 | 株式会社アネロファーマ・サイエンス | 形質転換用プラスミド |
US8755425B2 (en) * | 2010-06-30 | 2014-06-17 | Comtech Ef Data Corp. | Method and system for transmission of identification via metadata for repeating relays using spread-spectrum technology |
CN101880668B (zh) * | 2010-05-07 | 2012-05-23 | 广西大学 | 一种编码丝氨酸蛋白酶抑制剂的基因及其应用 |
EP2397145A1 (de) * | 2010-06-18 | 2011-12-21 | Nestec S.A. | L. johnsonii La1, B. longum NCC2705 und Immunerkrankungen |
CN101884782B (zh) * | 2010-06-29 | 2015-09-16 | 南昌大学 | 长双歧杆菌粘附抑制蛋白Aip在防治腹泻中的应用 |
CN105647715B (zh) | 2010-07-02 | 2019-10-25 | 宝洁公司 | 洗涤剂产品 |
BR112013000101A2 (pt) | 2010-07-02 | 2016-05-17 | Procter & Gamble | filamentos compreendendo mantas de não tecido com agente ativo e métodos de fabricação dos mesmos |
BR112013000044B1 (pt) | 2010-07-02 | 2022-01-04 | The Procter & Gamble Company | Método para a distribuição de agentes ativos a artigos de tecido ou superfícies duras |
EP2449891A1 (de) * | 2010-11-05 | 2012-05-09 | Nestec S.A. | Trinkjoghurtzubereitungen mit nicht-replizierenden probiotischen Mikroorganismen |
GB201021399D0 (en) * | 2010-12-16 | 2011-01-26 | Genetic Analysis As | Oligonucleotide probe set and methods of microbiota profiling |
TWI487530B (zh) * | 2011-01-10 | 2015-06-11 | 可產生高免疫激活反應之比菲德氏龍根菌分離株 | |
CN103649321B (zh) * | 2011-04-05 | 2019-07-16 | 拉勒曼德匈牙利流动性管理有限责任公司 | 用于通过添加交替电子受体改善微生物中的产品收率和产量的方法 |
CA2841451A1 (en) * | 2011-07-13 | 2013-01-17 | Anaeropharma Science, Inc. | Ischemic disease therapeutic agent |
GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
RU2527069C2 (ru) * | 2011-11-08 | 2014-08-27 | Автономная Некоммерческая Организация "Научно-исследовательский центр биотехнологи антибиотиков и других биологически активных веществ "БИОАН" | СПОСОБ ВИДОВОЙ И ШТАММОВОЙ ИДЕНТИФИКАЦИИ БИФИДОБАКТЕРИЙ ФИЛОТИПА Bifidobacterium longum |
BR112014021388A2 (pt) | 2012-02-29 | 2017-07-18 | Ethicon Endo Surgery Inc | composições de microbiota e métodos rela-cionados às mesmas |
US8686114B2 (en) | 2012-03-05 | 2014-04-01 | E I Du Pont De Nemours And Company | Variant sucrose transporter polypeptides |
US9161957B2 (en) | 2012-08-03 | 2015-10-20 | Life Well Lived, Llc | Compositions and methods for reducing blood alcohol content |
ES2821383T3 (es) * | 2012-10-17 | 2021-04-26 | Enterome | Firmas genéticas de trastornos inflamatorios relacionados con el hígado y la enfermedad de Crohn |
FR2999933B1 (fr) * | 2012-12-21 | 2020-01-31 | Société des Produits Nestlé S.A. | Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine |
GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
WO2015021530A1 (en) * | 2013-08-12 | 2015-02-19 | Mansel Griffiths | Antiviral methods and compositions comprising probiotic bacterial molecules |
KR20170002403A (ko) * | 2014-05-01 | 2017-01-06 | 가부시키가이샤 아네로파마·사이엔스 | 이종 폴리펩티드 발현 카세트 |
WO2015166641A1 (ja) | 2014-05-02 | 2015-11-05 | 国立大学法人信州大学 | 抗体遺伝子の発現・分泌システム |
GB2551642B (en) | 2014-10-31 | 2020-09-23 | Pendulum Therapeutics Inc | Methods and compositions relating to microbial treatment and diagnosis of disorders |
CA2969100C (en) * | 2014-12-03 | 2023-03-21 | Anaeropharma Science, Inc. | Coexpression plasmid |
US20180267037A1 (en) * | 2014-12-23 | 2018-09-20 | Evolve Biosystems Inc. | Method for the noninvasive detection of activated bifidobacteria |
EP3395351A1 (de) | 2014-12-23 | 2018-10-31 | 4D Pharma Research Limited | Immunmodulation |
JP6427278B2 (ja) | 2014-12-23 | 2018-11-21 | フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited | pirinポリペプチド及び免疫モジュレーション |
GB201508860D0 (en) | 2015-05-22 | 2015-07-01 | Nat Univ Ireland | Diagnostic method |
CN107847529B (zh) | 2015-06-15 | 2022-05-03 | 4D制药研究有限公司 | 包含细菌菌株的组合物 |
PT3650033T (pt) | 2015-06-15 | 2022-05-25 | 4D Pharma Res Ltd | Composições compreendendo estirpes bacterianas |
MA41060B1 (fr) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
BR112017025005A2 (pt) | 2015-06-15 | 2018-08-07 | 4D Pharma Research Limited | composições compreendendo cepas baterianas |
MA41010B1 (fr) | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
MA41013A (fr) | 2015-11-20 | 2017-08-30 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
GB201520497D0 (en) | 2015-11-20 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201520638D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201520631D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
EA035949B1 (ru) | 2016-03-04 | 2020-09-04 | 4Д ФАРМА ПиЭлСи | Применение композиции, содержащей бактериальный штамм вида blautia hydrogenotrophica, и способ лечения или предотвращения висцеральной гиперчувствительности |
GB201612191D0 (en) | 2016-07-13 | 2016-08-24 | 4D Pharma Plc | Compositions comprising bacterial strains |
CN105694892A (zh) * | 2016-03-16 | 2016-06-22 | 山东大学 | 一种表面带正电荷的CdSe量子点的制备方法 |
TW201821093A (zh) | 2016-07-13 | 2018-06-16 | 英商4D製藥有限公司 | 包含細菌菌株之組合物 |
US10738338B2 (en) | 2016-10-18 | 2020-08-11 | The Research Foundation for the State University | Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate |
CN106478812B (zh) * | 2016-10-21 | 2020-11-20 | 沈阳药科大学 | 丝氨酸蛋白酶抑制剂-3及其功能、制备方法和应用 |
GB201621123D0 (en) | 2016-12-12 | 2017-01-25 | 4D Pharma Plc | Compositions comprising bacterial strains |
JP6882519B2 (ja) | 2017-01-27 | 2021-06-02 | ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company | 発泡性凝集粒子を含む溶解性固形構造体形態の組成物 |
CA3059275A1 (en) | 2017-04-11 | 2018-10-18 | Chr. Hansen A/S | Lactase enzymes with improved properties |
MX2019013048A (es) | 2017-05-16 | 2019-12-11 | Procter & Gamble | Composiciones acondicionadoras para el cuidado del cabello en la forma de estructuras solidas solubles. |
MA48939B1 (fr) | 2017-05-22 | 2021-06-30 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
WO2018215782A1 (en) | 2017-05-24 | 2018-11-29 | 4D Pharma Research Limited | Compositions comprising bacterial strain |
HUE053488T2 (hu) | 2017-06-14 | 2021-06-28 | 4D Pharma Res Ltd | Baktériumtörzseket tartalmazó készítmények |
LT3638271T (lt) | 2017-06-14 | 2021-01-11 | 4D Pharma Research Limited | Kompozicijos, apimančios bakterines padermes |
MD3600364T2 (ro) | 2017-06-14 | 2020-12-31 | 4D Pharma Res Ltd | Compoziții care conţin tulpină bacteriană din genul Megasphaera și utilizări ale acestora |
AU2018326705A1 (en) | 2017-08-30 | 2020-03-05 | Pendulum Therapeutics, Inc. | Methods and compositions for treatment of microbiome-associated disorders |
US20200216787A1 (en) * | 2017-09-18 | 2020-07-09 | Dupont Nutrition Biosciences Aps | Riboflavinase enzymes and their use to prevent off flavor in brewing |
US11666514B2 (en) | 2018-09-21 | 2023-06-06 | The Procter & Gamble Company | Fibrous structures containing polymer matrix particles with perfume ingredients |
WO2020079116A1 (en) * | 2018-10-17 | 2020-04-23 | Chr. Hansen A/S | Lactase enzymes with improved properties at acidic ph |
CN110343672B (zh) * | 2018-12-27 | 2021-07-06 | 华东理工大学 | 一种抗尿苷酸反馈抑制的氨甲酰磷酸合成酶突变体及其应用 |
JP2021083433A (ja) * | 2019-11-29 | 2021-06-03 | 地方独立行政法人神奈川県立産業技術総合研究所 | 抗原結合分子、核酸組成物、ベクター組成物、細胞およびBifidobacterium longumの精製方法 |
EP4188554A1 (de) | 2020-07-31 | 2023-06-07 | The Procter & Gamble Company | Wasserlöslicher faserbeutel mit perlen zur haarpflege |
CN112458015B (zh) * | 2020-11-27 | 2021-11-19 | 石家庄君乐宝乳业有限公司 | 长双歧杆菌长亚种i772、其分离纯化方法及应用 |
KR102271333B1 (ko) * | 2021-01-29 | 2021-06-30 | 씨제이제일제당 (주) | 신규한 미코티온 리덕타제 변이체 및 이를 이용한 l-라이신 생산 방법 |
CN113957073B (zh) * | 2021-10-19 | 2023-09-01 | 山东寿光巨能金玉米开发有限公司 | 一种tkt基因启动子突变体及其在生产L-赖氨酸中的应用 |
CN114774335B (zh) * | 2022-06-22 | 2022-09-02 | 广东省科学院微生物研究所(广东省微生物分析检测中心) | 具有靶向葡萄糖激酶显著降血糖和降血脂功效的长双歧杆菌070103及其应用 |
CN116334263A (zh) * | 2023-04-21 | 2023-06-27 | 四川农业大学 | 一种用于检测鱼类鳃结节病病原菌的双重pcr引物、试剂盒及检测方法 |
CN116814822B (zh) * | 2023-08-25 | 2023-11-24 | 中国食品发酵工业研究院有限公司 | 一种长双歧杆菌婴儿亚种cicc 6069菌株的鉴定方法和应用 |
CN117551799B (zh) * | 2024-01-11 | 2024-03-19 | 广东海洋大学 | 用于鰤鱼诺卡氏菌菌株分型的引物组合、多重pcr鉴定方法及应用 |
CN118086539A (zh) * | 2024-03-05 | 2024-05-28 | 中国食品发酵工业研究院有限公司 | 长双歧杆菌婴儿亚种的PMA-qPCR活菌定量检测方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0687732B2 (ja) * | 1987-02-25 | 1994-11-09 | カルピス食品工業株式会社 | ビフイズス菌入り発酵乳の製造法 |
DE69219768T2 (de) * | 1992-07-06 | 1997-08-28 | Societe Des Produits Nestle S.A., Vevey | Milchbakterien |
US6737248B2 (en) * | 1996-01-05 | 2004-05-18 | Human Genome Sciences, Inc. | Staphylococcus aureus polynucleotides and sequences |
DE69737125T3 (de) * | 1996-10-31 | 2015-02-26 | Human Genome Sciences, Inc. | Streptococcus pneumoniae-Antigene und Impfstoffe |
JP2002529046A (ja) * | 1997-05-06 | 2002-09-03 | ヒューマン ジノーム サイエンシーズ,インコーポレイテッド | Enterococcus faecalisのポリヌクレオチドおよびポリペプチド |
JP4046389B2 (ja) * | 1997-09-04 | 2008-02-13 | 株式会社ヤクルト本社 | ビフィドバクテリウム・ブレーベ及びこれを用いた発酵豆乳 |
EP1227152A1 (de) * | 2001-01-30 | 2002-07-31 | Société des Produits Nestlé S.A. | Bakterienstamm und Genom des Bifidobacteriums |
-
2001
- 2001-01-30 EP EP01102050A patent/EP1227152A1/de not_active Withdrawn
-
2002
- 2002-01-30 DE DE60215461T patent/DE60215461T2/de not_active Expired - Lifetime
- 2002-01-30 WO PCT/EP2002/000958 patent/WO2002074798A2/en active Application Filing
- 2002-01-30 DK DK02718062T patent/DK1358332T3/da active
- 2002-01-30 EP EP02729925.4A patent/EP1360299B1/de not_active Expired - Lifetime
- 2002-01-30 CN CNB028072871A patent/CN100558896C/zh not_active Expired - Fee Related
- 2002-01-30 EP EP02718062A patent/EP1358332B1/de not_active Expired - Lifetime
- 2002-01-30 AT AT02718062T patent/ATE342986T1/de active
- 2002-01-30 PT PT2729925T patent/PT1360299E/pt unknown
- 2002-01-30 ES ES02718062T patent/ES2274019T3/es not_active Expired - Lifetime
- 2002-01-30 CN CNB028043189A patent/CN100516220C/zh not_active Expired - Fee Related
- 2002-01-30 ES ES02729925T patent/ES2420907T3/es not_active Expired - Lifetime
- 2002-01-30 CN CN2009101747374A patent/CN101671640B/zh not_active Expired - Lifetime
- 2002-01-30 US US10/470,565 patent/US7183101B2/en not_active Expired - Lifetime
- 2002-01-30 WO PCT/EP2002/000955 patent/WO2002060931A2/en not_active Application Discontinuation
- 2002-01-30 JP JP2002573806A patent/JP4570329B2/ja not_active Expired - Fee Related
- 2002-01-30 AU AU2002302360A patent/AU2002302360A1/en not_active Abandoned
- 2002-01-30 JP JP2002561500A patent/JP4249483B2/ja not_active Expired - Fee Related
- 2002-01-30 AU AU2002247668A patent/AU2002247668A1/en not_active Abandoned
- 2002-01-30 CA CA2435664A patent/CA2435664C/en not_active Expired - Fee Related
- 2002-01-30 PT PT02718062T patent/PT1358332E/pt unknown
- 2002-01-30 WO PCT/EP2002/000956 patent/WO2002060932A2/en active IP Right Grant
- 2002-01-30 US US10/470,559 patent/US7700315B2/en not_active Expired - Lifetime
- 2002-01-30 AU AU2002249151A patent/AU2002249151A1/en not_active Abandoned
- 2002-01-30 CA CA2436049A patent/CA2436049C/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60215461D1 (de) | Serpin von bifidobakterien | |
DK1032674T3 (da) | Chlamydia pneumoniae genomisk sekvens og polypeptider, fragmenter deraf og anvendelser deraf, især til diagnosen, forebyggelsen og behandlingen af infektion | |
WO1999028475A3 (en) | Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection | |
AU2002345084A1 (en) | Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced succ or sucd gene | |
DE69841894D1 (de) | Äusseres Membranpolypeptid von Chlamydia pneumoniae sowie Fragmente davon und deren Verwendung, insbesondere zur Diagnose, Prävention und Behandlung einer Infektion | |
GR3031152T3 (en) | 5' to 3' exonuclease mutations of thermostable dna polymerases | |
WO2003004675A3 (en) | Process for the preparation of l-amino acids using strains of the enterobacteriaceae family | |
ATE256196T1 (de) | Chimäre vektoren, die die verpackungsregion eines phagengenoms und einen teil des genoms eines eukaryontischen virus enthalten | |
AU2003223971A8 (en) | La1 - the genome of a lactobacillus strain | |
WO2003056021A3 (en) | Modified tetracycline repressor protein compositions and methods of use | |
Sul et al. | Rapid identification of Lactobacillus and Bifidobacterium in probiotic products using multiplex PCR | |
RU94046362A (ru) | Последовательности днк, плазмиды, применение плазмиды, растения, бактерии, применение последовательности днк, дрожжевые штаммы | |
Meyer et al. | Taxonomic heterogeneity, as shown by siderotyping, of strains primarily identified as Pseudomonas putida | |
EP1788075A4 (de) | Grosstechnisch geeigneter mikroorganismus | |
WO2002068662A8 (en) | Plasmid originated from bifidobacterium, recombinant expression vector using the plasmid and transformation method | |
Esikova et al. | Key role of the dca genes in ε-caprolactam catabolism in Pseudomonas strains | |
WO2001060975A3 (en) | Gene disruption methodologies in fungi for drug target discovery | |
AU2002346803A1 (en) | Genes encoding for carbon metabolism and energy-producing proteins | |
Juárez et al. | Biosensor libraries harness large classes of binding domains for allosteric transcription regulators | |
AU2002342763A1 (en) | Process for the preparation of non-aromatic l-amino acids using strains of the enterobacteriaceae family | |
WO2003076636A3 (en) | Process for the preparation of l-amino acids using strains of the enterobacteriaceae family | |
Gharbia et al. | Unique expression mechanisms among oral anaerobes: implications of genome size and regulatory components | |
ES2208033B1 (es) | Metodo de identificacion de microorganismos basado en la amplificacion de dna. | |
Schuster et al. | Plenarvorträge | |
Clancy et al. | Correction for Clancy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |